Strain identifier

BacDive ID: 12759

Type strain: No

Species: Pseudomonas aeruginosa

Strain Designation: Boston 41501

Culture col. no.: DSM 1117, ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025, UCCCB116

Strain history: ATCC <- A. Madeiros, Boston 41501

NCBI tax ID(s): 1236529 (strain), 287 (species)

« Browse strain by BacDive ID »

expand / minimize allblue arrow down

Exclude non-curated data/information

Pseudomonas aeruginosa Boston 41501 is an aerobe, mesophilic human pathogen that has multiple antibiotic resistances and was isolated from blood culture.

  1. antibiotic resistance
  2. aerobe
  3. human pathogen
  4. mesophilic
  5. 16S sequence
  6. Bacteria
  7. genome sequence
  • Availability in culture collections External linksarrow_down
  • [Ref.: #565] Culture collection no. DSM 1117, ATCC 27853, CCM 3955, CCUG 17619, CECT 108, CIP 76.110, JCM 6119, LMG 6395, NCIMB 12469, WDCM 00025, UCCCB116
    [Ref.: #20218] Associated Passport(s) in StrainInfo 16502, 16493, 219950, 16497, 16499, 231420, 335125, 16492, 16506, 866251
    Literature: Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries.
    Topicarrow to sort Titlearrow to sort Authorsarrow to sort Journalarrow to sort DOIarrow to sort Yeararrow to sort
    Pathogenicity Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Pollock HM, Minshew BH, Kenny MA, Schoenknecht FD Antimicrob Agents Chemother 10.1128/AAC.14.3.360 1978 *
    Pathogenicity Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study. Prior RB, Fass RJ Antimicrob Agents Chemother 10.1128/AAC.14.3.507 1978 *
    Pathogenicity Standardization of direct susceptibility test for blood cultures. Fay D, Oldfather JE J Clin Microbiol 10.1128/jcm.9.3.347-350.1979 1979 *
    Pathogenicity Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test. Woolfrey BF, Ramadei WA, Quall CO Am J Clin Pathol 10.1093/ajcp/72.5.861 1979 *
    Pathogenicity Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Fass RJ, Barnishan J Antimicrob Agents Chemother 10.1128/AAC.16.5.622 1979 *
    Pathogenicity Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study. Washington JA 2nd, Yu PK, Gavan TL, Schoenknecht FD, Thornsberry C Antimicrob Agents Chemother 10.1128/AAC.15.3.400 1979 *
    Pathogenicity Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Barclay ML, Begg EJ, Chambers ST Antimicrob Agents Chemother 10.1128/AAC.36.9.1951 1992 *
    Pathogenicity Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities. Gunes HS, Cosar G Arzneimittelforschung 1992 *
    Enzymology Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. McGrath BJ, Bailey EM, Lamp KC, Rybak MJ Antimicrob Agents Chemother 10.1128/AAC.36.12.2741 1992 *
    Pathogenicity Synthesis and evaluation of antimicrobial activity of new 4-nitroso and 4-diazopyrazole derivatives. Daidone G, Plescia S, Raffa D, Maggio B, Schillaci D Farmaco 1992 *